Santhera Pharmaceuticals and Idis

LIESTAL, Switzerland and WEYBRIDGE, England - - Santhera and Idis Partner to Facilitate Patient Access to Friedreich's Ataxia Drug Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on orphan neuromuscular diseases and Idis announced today that Catena(R) will be made available on a named patient basis in Europe.